Myeloproliferative Neoplasms (MPNs) Patient Registry

ConditionsPrimary Myelofibrosis Polycythemia Vera Essential Thrombocythemia Mastocytosis Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative Leukemia, Myelomonocytic, Juvenile Chronic Eosinophilic Leukemia-not Otherwise Specified Myelodysplastic-Myeloproliferative Diseases Neoplasms Leukemia, Myelomonocytic, Chronic

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

AgeNot listed

SponsorUniversity Health Network, Toronto

About this trial

The mandate of this MPN registry is to collect clinical information, including molecular results, from consenting patients with a variety of MPNs at different time points during the course of their disease.

Eligibility criteria

Qualifiers

Atypical CML (aCML)

Chronic eosinophilic leukemia-not otherwise specified (CEL, NOS),

Chronic myelomonocytic leukemia (CMML)

Chronic neutrophilic leukemia (CNL),

Disqualifiers

None

Trial design

Treatments tested in this trial

Observational

Treatment groups

5,000 Participants

are divided into 1 treatment group

Locations

Princess Margaret Cancer CentreM5G 1Z5, TorontoOntario, Canada

Sponsors and collaborators

University Health Network, Toronto

Lead sponsor

Source ClinicalTrials.gov